Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AtmosAir is a private indoor air quality technology company that develops and sells commercial air purification, monitoring, and sensor systems for buildings. Its core offerings center on bi-polar ionization devices integrated into HVAC systems, along with real-time indoor air quality monitoring, portable products, and complementary clean-air technologies such as HEPA filtration and UVC. The company serves sectors including healthcare, hospitality, education, commercial real estate, sports venues, government, and residential markets. AtmosAir positions its products as solutions to reduce airborne contaminants, odors, volatile organic compounds, particles, and microorganisms while also supporting energy efficiency and healthier indoor environments. The business is not a biotech or pharmaceutical drug developer, but it is health-related through environmental health and building air quality.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AtmosAir Solutions.